A 13-year-old male patient presented with a primary complaint of reduced vision in both eyes for the past 15 days at LV ...

Researchers from Children's Hospital of Philadelphia (CHOP) have discovered the underlying biology that identifies a subset ...

TUESDAY, Dec. 3, 2024 (HealthDay News) -- A newly approved immunotherapy can help adults with a difficult-to-treat form of ...

A novel CAR T-cell therapy has benefitted patients with relapsed acute lymphoblastic leukemia, showing high response rates in ...

In a recent study published in Nature Cancer, researchers explore treatment resistance and relapse in T-cell acute ...

Immunotherapies have shaped the cancer research space over the past decade, proving effective for the treatment of some ...

Adoptive cell transfer with chimeric antigen receptor (CAR)-expressing T cells can induce remarkable complete responses in ...

An expert highlighted unmet needs in treating T-cell acute lymphoblastic leukemia and where research may focus in the future.

Researchers have discovered the underlying biology that identifies a subset of patients with acute lymphoblastic leukemia who ...

ALL, certain drugs work for some patients who relapse, but these drugs are not effective for all patients who relapse.

By Vijay Kumar Malesu Phase 1b–2 trial evaluates the potential of CAR T-cell therapy obe-cel in relapsed or refractory B-cell ...